Low-Grade Gliomas: Evolving Approaches to Care

Low-Grade Gliomas: Evolving Approaches to Care

Dr. Priya Kumthekar, Neuro-Oncology Section Editor for CANCER, and Dr. Helen Shih, Radiation Oncology Section Editor for CANCER, discuss the current treatment landscape for low-grade gliomas with a focus on the evolving role of isocitrate dehydrogenase (IDH) inhibitors. Drawing on findings from the INDIGO trial, they reflect on how recent evidence has informed ongoing discussions around the use of IDH inhibitors, alongside their perspectives on treatment planning and real-world clinical considerations. The conversation also emphasizes the importance of engaging patients in shared decision making throughout the course of care.

Drs. Kumthekar and Shih invite investigators in neuro-oncology, radiation oncology, and related disciplines to consider submitting their research to CANCER. Their closing remarks highlight the journal’s global reach, supportive editorial staff, and connection to the mission of the American Cancer Society.

Learn more about submitting your work to CANCER: https://acsjournals.onlinelibrary.wiley.com/journal/10970142/homepage/why-submit

Original music by J.Gilman.

Follow CANCER on social media: x.com/JournalCancer instagram.com/acsjournalcancer linkedin.com/company/acs-journals

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(26)

Annual Report to the Nation: Cancer Trends and Progress Against Lung Cancer

Annual Report to the Nation: Cancer Trends and Progress Against Lung Cancer

What do the latest data tell us about cancer in the United States, and what’s behind the substantial progress against lung cancer over the past two decades? In this episode of CancerSpeak, Jane Henley...

22 Syys 24min

Advancing Pediatric and AYA Oncology: Perspectives from the Editors

Advancing Pediatric and AYA Oncology: Perspectives from the Editors

Where is pediatric and adolescent and young adult (AYA) oncology headed—and what research is needed to move the field forward? In this episode of CancerSpeak, Dr. Nirali Shah, Editor-in-Chief of Pedia...

9 Syys 21min

Optimizing Asparaginase and Blinatumomab in Frontline Acute Lymphoblastic Leukemia

Optimizing Asparaginase and Blinatumomab in Frontline Acute Lymphoblastic Leukemia

What are the latest recommendations for frontline acute lymphoblastic leukemia (ALL) treatment? In this episode of CancerSpeak, Cancer Hematologic Malignancies Section Editor Dr. Courtney DiNardo is j...

11 Elo 10min

Top Advances of the Year: Palliative and Supportive Care in Oncology

Top Advances of the Year: Palliative and Supportive Care in Oncology

Palliative and supportive care helps reduce suffering, manage symptoms, and improve quality of life for people living with cancer, yet many patients still face barriers to accessing these services. Re...

13 Heinä 21min

Post-MPN AML: Real-World Outcomes and Ongoing Challenges

Post-MPN AML: Real-World Outcomes and Ongoing Challenges

Have newer therapies improved outcomes for patients with acute myeloid leukemia after myeloproliferative neoplasms, or post-MPN AML? In this episode of CancerSpeak, Cancer Hematologic Malignancies Sec...

23 Kesä 13min

Antibody–Drug Conjugates: Clinical Perspectives from Europe

Antibody–Drug Conjugates: Clinical Perspectives from Europe

Dr. Daniel Morgensztern, Section Editor of Chest and Lung Disease for the journal Cancer, is joined by Dr. Emiliano Calvo and Dr. André Mansinho to discuss a new supplement in Cancer focused on recent...

2 Kesä 22min

A New Home for Pediatric and AYA Oncology Research

A New Home for Pediatric and AYA Oncology Research

In this episode of CancerSpeak, Dr. Nirali Shah is joined by Dr. William Dahut, Chief Scientific Officer of the American Cancer Society, and Dr. Suresh Ramalingam, Editor-in-Chief of Cancer, to discus...

19 Touko 13min

Suosittua kategoriassa Tiede

utelias-mieli
rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
rss-duodecim-lehti
rss-hereilla
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
docemilia
rss-lihavuudesta-podcast
mielipaivakirja
rss-politiikasta-podcast
rss-bios-podcast
radio-antro